Searched for
DIABETES DRUG LAWSUIT
Did Ozempic manufacturer Novo Nordisk hide drug death reports? Here’s what FDA said about side-effect reportingDespite ongoing debate, medications such as Ozempic continue to rank among the most commonly prescribed treatments for weight management an...- Novo Nordisk sued in US for allegedly monopolizing diabetes drug VictozaDanish drugmaker Novo Nordisk faces a class action lawsuit in New York. The company is accused of using its patents to keep a monopoly on i...
- HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglut...
- Is Novo Nordisk facing its “Nokia moment”? Stock tumbles to $50 from a year-high of $139 amid disruptive rivals and shifting market forcesNovo Nordisk’s stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, and legal ch...
- Americans hungry for weight-loss drugs grapple with supply and insurance hurdlesDespite supply chain issues easing, patients seeking weight-loss drugs like Wegovy and Zepbound are turning to cheaper compounded versions ...
- White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearlyThe Biden administration announced agreements with drug companies to lower the cost of 10 major Medicare medications, potentially saving ta...
- Can yogurt keep type 2 diabetes at bay? Here's what the experts sayAmong the allowed qualified health claims: consuming some types of cocoa may reduce heart disease and cranberry juice might reduce the risk...
- Novo Nordisk, maker of Ozempic and Wegovy sues two pharmacies for ‘selling impure drugs’Over alleged selling of contaminated drugs, two Florida-based pharmacies have been sued by Novo Nordisk. The company claims that the substa...
- US names first 10 drugs for Medicare price negotiationThe Biden administration has released a list of 10 prescription medicines that will be subject to price negotiations by the U.S. Medicare h...
- Glenmark Pharma Q4 Results: Profit declines 12.3% on higher input costs and lower demandGlenmark Pharmaceuticals' Q4 consolidated profit before exceptional items and tax was INR3.09bn ($37.78m) for the quarter ended 31 March, d...
- Lupin Q2 results: Firms posts Rs 2,095 crore loss due to one-off impairmentsDuring the quarter, the company booked a provision of Rs 1879.6 crore towards litigation and settlement related to diabetic drug Glumetza c...
- Novartis pays $678 million to resolve suit over sham doctor outingsThe settlement of the lawsuit was announced by Acting Manhattan U.S. Attorney Audrey Strauss, who said the company splurged on "speaking fe...
- Sun, Dr Reddy's among 7 Indian pharma majors sued in US for price riggingThe lawsuit widens a complaint of price collusion filed in 2016, which is still pending in US courts after being first investigated in 2014.
- US generics probe reveals startling detail of price fixing in Doxycycline and GlyburideA Bloomberg report said two executives of Heritage Pharma – the US arm of Indian drug maker Emcure - are preparing to plead guilty to price...
- Patent row: Merck gets interim relief from HCThe Delhi High Court has restrained an Indian pharmaceutical company from launching its diabetes drug manufactured by Merck Sharp and Dohme...
- US drugmaker MSD gets interim relief on diabetes drug patent rowThe US pharma major alleged the Indian company was coming out with the diabetes drug with Sitagliptin molecule and its derivatives salt in ...
- GlaxoSmithKline settles tainted drugs suit for $750 mnGSK was accused of manufacturing and selling certain adulterated drugs that were made at its now-closed facility in Cidra, Puerto Rico.
- Experts urge US to restrict drug AvandiaA majority of members of a key advisory committee recommended Wednesday that the US government allow diabetes drug Avandia to stay on the m...
- Lupin sends notice to Oscient over cholesterol genericIndian pharma major Lupin has sent a legal notice to US-based Oscient Pharmaceuticals to inform them that they are seeking regulatory appro...
- New study adds to worries about diabetes drug classAnother study has found that diabetes drugs intended to help patients live longer, healthier lives may in fact increase the chances they wi...
Load More
